2023 Q4 Form 20-F Financial Statement

#000121390024027359 Filed on March 28, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $0.00 $142.0K $0.00
YoY Change -66.27% -100.0%
Cost Of Revenue $0.00 $61.00K $0.00
YoY Change -90.77% -100.0%
Gross Profit $0.00 $81.00K $0.00
YoY Change -133.75% -100.0%
Gross Profit Margin 57.04%
Selling, General & Admin $986.0K $4.319M $1.087M
YoY Change -9.29% 1.27% -67.22%
% of Gross Profit 5332.1%
Research & Development $1.611M $6.994M $1.473M
YoY Change 9.37% 12.26% -79.56%
% of Gross Profit 8634.57%
Depreciation & Amortization $46.00K $171.0K $35.00K
YoY Change 31.43% 755.0% -57.32%
% of Gross Profit 211.11%
Operating Expenses $2.597M $11.48M $2.560M
YoY Change 1.45% 9.42% -75.67%
Operating Profit -$2.597M -$11.40M -$2.560M
YoY Change 1.45% 6.22% -75.13%
Interest Expense $72.00K $255.0K $102.0K
YoY Change -29.41% -1.92% 39.73%
% of Operating Profit
Other Income/Expense, Net $255.0K
YoY Change -1.92%
Pretax Income -$2.525M -$11.15M -$2.458M
YoY Change 2.73% 6.42% -75.95%
Income Tax
% Of Pretax Income
Net Earnings -$2.525M -$11.15M -$2.458M
YoY Change 2.73% 6.42% -75.95%
Net Earnings / Revenue -7850.7%
Basic Earnings Per Share -$4.30
Diluted Earnings Per Share -$0.84 -$4.31 -$0.15
COMMON SHARES
Basic Shares Outstanding 2.998M shares 2.587M shares 16.09M shares
Diluted Shares Outstanding 2.587M shares

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.066M $3.066M $8.270M
YoY Change -62.93% -62.93%
Cash & Equivalents $3.066M $3.066M $8.270M
Short-Term Investments
Other Short-Term Assets $559.0K $559.0K $225.0K
YoY Change 148.44% 25.06% -52.33%
Inventory $977.0K $977.0K
Prepaid Expenses $87.00K $118.0K
Receivables $0.00 $0.00 $115.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.602M $4.602M $8.832M
YoY Change -47.89% -47.89% 266.78%
LONG-TERM ASSETS
Property, Plant & Equipment $1.319M $1.319M $449.0K
YoY Change 193.76% -17.56% -21.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.319M $1.319M $1.600M
YoY Change -17.56% -17.56% -20.12%
TOTAL ASSETS
Total Short-Term Assets $4.602M $4.602M $8.832M
Total Long-Term Assets $1.319M $1.319M $1.600M
Total Assets $5.921M $5.921M $10.43M
YoY Change -43.24% -43.24% 136.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $185.0K $185.0K $56.00K
YoY Change 230.36% 230.36%
Accrued Expenses $285.0K $1.433M $208.0K
YoY Change 37.02% 409.96% 4.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.610M $2.610M $1.369M
YoY Change 90.65% 90.65% -11.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $524.0K $524.0K $798.0K
YoY Change -34.34% -34.34%
Total Long-Term Liabilities $524.0K $524.0K $798.0K
YoY Change -34.34% -34.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.610M $2.610M $1.369M
Total Long-Term Liabilities $524.0K $524.0K $798.0K
Total Liabilities $3.134M $3.134M $2.167M
YoY Change 44.62% 44.62% -21.85%
SHAREHOLDERS EQUITY
Retained Earnings -$65.96M -$54.81M
YoY Change 20.34% 23.62%
Common Stock $68.00K $46.00K
YoY Change 47.83% 84.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.787M $2.787M $8.265M
YoY Change
Total Liabilities & Shareholders Equity $5.921M $5.921M $10.43M
YoY Change -43.24% -43.24% 136.5%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$2.525M -$11.15M -$2.458M
YoY Change 2.73% 6.42% -75.95%
Depreciation, Depletion And Amortization $46.00K $171.0K $35.00K
YoY Change 31.43% 755.0% -57.32%
Cash From Operating Activities -$1.909M -$10.52M -$2.149M
YoY Change -11.17% 5.38% -56.96%
INVESTING ACTIVITIES
Capital Expenditures $8.000K $152.0K $14.00K
YoY Change -42.86% 424.14% -105.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.000K -$152.0K -$14.00K
YoY Change -42.86% 424.14% -94.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.000K 5.397M 0.000
YoY Change -67.59%
NET CHANGE
Cash From Operating Activities -1.909M -10.52M -2.149M
Cash From Investing Activities -8.000K -152.0K -14.00K
Cash From Financing Activities 2.000K 5.397M 0.000
Net Change In Cash -1.915M -5.273M -2.163M
YoY Change -11.47% -179.38% -58.63%
FREE CASH FLOW
Cash From Operating Activities -$1.909M -$10.52M -$2.149M
Capital Expenditures $8.000K $152.0K $14.00K
Free Cash Flow -$1.917M -$10.67M -$2.163M
YoY Change -11.37% 6.59% -54.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.91
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1143518 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1771803 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2587290 shares
CY2023 rvsn Decrease Of Deferred Expenses Against Additional Paid In Capital
DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital
usd
CY2021 rvsn Decrease Of Deferred Expenses Against Additional Paid In Capital
DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital
usd
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41334
CY2023 dei Entity Registrant Name
EntityRegistrantName
RAIL VISION LTD.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L3
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
15 Ha’Tidhar St
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Ra’anana
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
4366517
CY2023 dei Entity Address Country
EntityAddressCountry
IL
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2998278 shares
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
1197
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
888000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
61000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
661000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
657000 usd
CY2023 us-gaap Gross Profit
GrossProfit
81000 usd
CY2022 us-gaap Gross Profit
GrossProfit
-240000 usd
CY2021 us-gaap Gross Profit
GrossProfit
231000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7145000 usd
CY2023 dei Auditor Name
AuditorName
Brightman Almagor Zohar & Co.
CY2023 dei Auditor Location
AuditorLocation
Tel Aviv, Israel
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3066000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8270000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
223000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
222000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
115000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
977000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
336000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
225000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4602000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
8832000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
889000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1151000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
430000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1319000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1600000 usd
CY2023Q4 us-gaap Assets
Assets
5921000 usd
CY2022Q4 us-gaap Assets
Assets
10432000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
185000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
56000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
285000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
281000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
2140000 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1032000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2610000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1369000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
524000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
798000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3134000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2167000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.08
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.08
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12500000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
12500000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2998278 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2998278 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1987005 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1987005 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
68000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68681000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63033000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65962000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54814000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2787000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8265000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5921000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10432000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
142000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
421000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6230000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7208000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4339000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4265000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3316000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-11403000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-10735000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-10293000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
255000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
260000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
73000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11148000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-10475000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-10220000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.3
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.91
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.94
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2587290 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1771803 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1143518 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
907000 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
127000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
859000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-10220000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8327000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
11965000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
13587000 usd
CY2022 rvsn Stock Issued During Period Conversion Of Convertible Debt Into Ordinary Shares Upon Completion Of Initial Public Offering
StockIssuedDuringPeriodConversionOfConvertibleDebtIntoOrdinarySharesUponCompletionOfInitialPublicOffering
1000000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
505000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-10475000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8265000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8265000 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
5397000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
273000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11148000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2787000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-11148000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-10475000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-10220000 usd
CY2023 us-gaap Depreciation
Depreciation
171000 usd
CY2022 us-gaap Depreciation
Depreciation
150000 usd
CY2021 us-gaap Depreciation
Depreciation
142000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
273000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
505000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1055000 usd
CY2023 rvsn Exchange Rate Changes On Cash And Cash Equivalents
ExchangeRateChangesOnCashAndCashEquivalents
-70000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-115000 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
111000 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-163000 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
381000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
977000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-159000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-91000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
129000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-83000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
87000 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
1108000 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-82000 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-540000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10518000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9981000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9948000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
152000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
273000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-152000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-273000 usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2000000 usd
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5000000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1000000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
127000 usd
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5397000 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
13643000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5397000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16653000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5127000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5203000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6643000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5094000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8492000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1849000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6943000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3289000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8492000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1849000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
458000 usd
CY2022 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
11965000 usd
CY2022 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1000000 usd
CY2022 rvsn Decrease Of Deferred Expenses Against Additional Paid In Capital
DecreaseOfDeferredExpensesAgainstAdditionalPaidInCapital
56000 usd
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
8830000 usd
CY2023Q4 rvsn Number Of Share
NumberOfShare
1 shares
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><b>B.</b></td><td style="text-align: justify"><b>Use of estimates in the preparation of financial statements:</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect reported amounts and disclosures made. Actual results could differ from those estimates.</p>
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
505000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
383000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
89000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
977000 usd
CY2023Q4 us-gaap Government Contract Receivable
GovernmentContractReceivable
88000 usd
CY2022Q4 us-gaap Government Contract Receivable
GovernmentContractReceivable
27000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
14000 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
49000 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
39000 usd
CY2023Q4 rvsn Deferred Cost Of Revenues
DeferredCostOfRevenues
85000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
87000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
118000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
23000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
31000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
336000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
225000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1430000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1278000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
829000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
430000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
449000 usd
CY2023 us-gaap Depreciation
Depreciation
171000 usd
CY2022 us-gaap Depreciation
Depreciation
150000 usd
CY2021 us-gaap Depreciation
Depreciation
142000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
868000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
824000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
280000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
208000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
992000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
2140000 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1032000 usd
CY2022Q2 us-gaap Payments For Royalties
PaymentsForRoyalties
213000 usd
CY2023Q1 us-gaap Contract With Customer Asset Purchase
ContractWithCustomerAssetPurchase
140000 usd
CY2023 us-gaap Revenues
Revenues
142000 usd
CY2022Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
338459 shares
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
127000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000 usd
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1000000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
30266 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
33.44
CY2022Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13587000 usd
CY2022Q2 rvsn Number Of Ordinary Shares And Warrants Percentage
NumberOfOrdinarySharesAndWarrantsPercentage
0.15 pure
CY2020Q1 rvsn Warrants To Purchase Shares
WarrantsToPurchaseShares
24431 shares
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2023Q2 rvsn Gross Proceeds
GrossProceeds
6000000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
493421 shares
CY2023Q2 rvsn Issuance Of Warrants
IssuanceOfWarrants
493424 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.72
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2023Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000 usd
CY2023 rvsn Warrant Exercisable Shares
WarrantExercisableShares
493421 shares
CY2023 rvsn Gross Proceeds
GrossProceeds
3000000 usd
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
6.08
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
291544 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.70 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.014 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021Q4 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
3135 shares
CY2021Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
49.12
CY2023Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P3Y
CY2023Q1 rvsn Warrants Purchase
WarrantsPurchase
1563 shares
CY2023Q1 rvsn Warrants To Purchase Shares
WarrantsToPurchaseShares
1563 shares
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
20
CY2023Q1 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
24
CY2023 rvsn Schedule Of General And Administrative Table Tex Block
ScheduleOfGeneralAndAdministrativeTableTexBlock
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">Payroll and related expenses</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,815</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,845</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,508</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Share-based payment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">212</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">323</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">411</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,635</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,451</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,133</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Travel expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">61</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Rent and office maintenance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Marketing and others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">457</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">393</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">75</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,339</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">4,265</td><td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,316</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.13
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.48
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
302000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
54237000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12474000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9843000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12474000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9843000 usd
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
22000 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
79000 ils
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
25000 usd
CY2023 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company has an option to extend the lease period for another five years from September 9, 2026, to September 8, 2031, with a monthly rent of between NIS 96 thousand (approx. $30) and NIS 102 thousand (approx. $32) over the additional lease period linked with the Israeli Consumer Price Index.
CY2023 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2026-09-08
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
375000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
357000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
405000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
313000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
317000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
219000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
849000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
40000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
809000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.051 pure
CY2023 rvsn Credit Facility Initial Term
CreditFacilityInitialTerm
P10Y
CY2023 us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
1500000 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
3000000 usd
CY2023 rvsn Percentage Of Additional Loans Of Accure Interest Rate
PercentageOfAdditionalLoansOfAccureInterestRate
0.12 pure
CY2023 rvsn Credit Facility Of Financing Obligations
CreditFacilityOfFinancingObligations
7500000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
1500000 usd
CY2023 rvsn Aggregate Amount Of Equity Financing Transaction
AggregateAmountOfEquityFinancingTransaction
5000000 usd
CY2023Q4 us-gaap Other Additional Capital
OtherAdditionalCapital
500000 usd
CY2023 rvsn Aggregate Exercise Amount
AggregateExerciseAmount
7500000 usd
CY2023 rvsn Percentage Of Premium Share Price
PercentageOfPremiumSharePrice
1.50 pure
CY2023 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.408
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
18382353 shares
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1000000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y6M
CY2024Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3500000 usd
CY2024Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
500000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4955000 usd
CY2023 rvsn Company Transaction
CompanyTransaction
D.On February 21, 2024, the Company convened an extraordinary general meeting of shareholders (the “Meeting”). At the Meeting, the shareholders of the Company approved (i) the cancelation of the nominal value of the Company’s registered and issued share capital; (ii) an increase of the Company’s registered share capital from 12,500,000 ordinary shares to 100,000,000 ordinary shares; and to amend the Company’s Amended and Restated Articles of Association accordingly.
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.94
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.3
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023 rvsn Stock Issued During Period Value Exercise Warrants
StockIssuedDuringPeriodValueExerciseWarrants
usd
CY2022 rvsn Exchange Rate Changes On Cash And Cash Equivalents
ExchangeRateChangesOnCashAndCashEquivalents
usd
CY2021 rvsn Exchange Rate Changes On Cash And Cash Equivalents
ExchangeRateChangesOnCashAndCashEquivalents
usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2023 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2023 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
usd
CY2022Q4 rvsn Deferred Cost Of Revenues
DeferredCostOfRevenues
usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2023Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5397000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
500000 usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001743905

Files In Submission

Name View Source Status
0001213900-24-027359-index-headers.html Edgar Link pending
0001213900-24-027359-index.html Edgar Link pending
0001213900-24-027359.txt Edgar Link pending
0001213900-24-027359-xbrl.zip Edgar Link pending
ea0202584-20f_railvision.htm Edgar Link pending
ea020258401ex12-1_railvision.htm Edgar Link pending
ea020258401ex12-2_railvision.htm Edgar Link pending
ea020258401ex13-1_railvision.htm Edgar Link pending
ea020258401ex13-2_railvision.htm Edgar Link pending
ea020258401ex15-1_railvision.htm Edgar Link pending
ea020258401ex2-1_railvision.htm Edgar Link pending
ea020258401ex4-4_railvision.htm Edgar Link pending
ea020258401ex97-1_railvision.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_004.jpg Edgar Link pending
image_005.jpg Edgar Link pending
image_006.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
ea0202584-20f_railvision_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rvsn-20231231.xsd Edgar Link pending
rvsn-20231231_def.xml Edgar Link unprocessable
rvsn-20231231_lab.xml Edgar Link unprocessable
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
rvsn-20231231_cal.xml Edgar Link unprocessable
rvsn-20231231_pre.xml Edgar Link unprocessable